Imaging is one of the most powerful tools in oncology, but it is frequently misunderstood. Patients often assume that a more expensive scan must be "better." In reality, each modality answers different questions.
CT: the workhorse of staging anatomy
CT is fast, widely available, and excellent for mapping anatomy. It is often used to detect metastases and plan surgery. Particularly strong for lung evaluation and broad staging surveys.
MRI: soft tissue precision
MRI provides superior soft tissue contrast and is often preferred for pelvic staging in rectal cancer, liver lesion characterization, and brain/spine evaluation.
PET/CT: metabolic activity mapping
PET/CT measures metabolic activity. It can be useful for detecting occult disease and clarifying indeterminate findings. However, PET is not "the truth" -- inflammation and infection can cause false positives, and some tumor types can produce false negatives.
Practical way to discuss imaging
Ask these questions:
1. What is the exact clinical question this scan should answer?
2. If the scan shows X, how will it change the plan?
3. If the scan shows nothing new, what is the next step?
4. Are there alternative tests with similar value and lower burden?
Common imaging traps
- Doing a test without a clear decision use
- Over-interpreting a single indeterminate lesion
- Treating PET activity as a diagnosis without context
- Repeating imaging too frequently without clinical impact
Imaging is most powerful when it is decision-linked. The right scan is not the largest scan -- it is the scan that changes the plan in a defensible way.